LONDON--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, and NHS England today announced the availability of the easy ...

EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the publication of a ...

Dexcom has launched its ONE+ continuous glucose monitoring (CGM) device in the UK, alongside a report that details high rates of anxiety and depression amongst type 2 diabetes (T2D) patients. The ...

Dexcom has been abuzz this year amid the European approval—and submission for FDA approval in the U.S.—for its next-generation G7 continuous glucose monitoring system, which promises more accurate ...

- Dexcom在美国“超级碗”广告中宣布在美国推出新一代Dexcom G7连续血糖监测（CGM）系统，这是目前准确度更高、更容易使用的CGM系统，可帮助糖尿病患者更好地管理他们的健康。 - 第二季度播出的新广告将在全球顶级规模的盛大舞台上唤起人们对糖尿病管理技术 ...